ArticleTurkish journal of physical medicine and rehabilitation2026
Validation and cross-cultural adaptation of the Sarcopenia Disease Risk Perception Scale among Turkish older adults.
Article in Turkish journal of physical medicine and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aims to determine the validity and reliability of the Turkish version of the Sarcopenia Disease Risk Perception Scale (SDRPS-TR), addressing the lack of disease-specific risk perception tools in Türkiye. Patients and methods: The validation process was conducted in two phases: Results: Content validity index values ranged between 0.85 and 1.00, confirming strong content validity. Exploratory factor analysis identified a two-factor structure (perceived susceptibility and perceived severity), explaining 55.8% of the variance. Confirmatory factor analysis confirmed the model fit with acceptable indices. The SDRPS-TR demonstrated high internal consistency (Cronbach's alpha=0.929) and excellent test-retest reliability (ICC=0.844, 95% confidence interval 0.764-0.907). Conclusion: The SDRPS-TR is a valid and reliable instrument for measuring sarcopenia risk perception among Turkish older adults. The availability of SDRPS-TR provides important opportunities for the early identification of at-risk individuals. It also supports clinical screening and community-based health education efforts, contributing to timely intervention for sarcopenia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.